Reassessing autotransplantation for acute myeloid leukaemia in first remission - A matched pair analysis of autologous marrow vs peripheral blood stem cells

Bone Marrow Transplantation

Volumn 33, Issue 12, 2004, Pages 1209-1214

  Sirohi, B ^a   Powles, R ^a,d   Kulkarni, S ^b   Rudin, C ^a   Frassoni, F ^b   Bacigalupo, A ^b   Singhal, S ^a   Vaidya, S ^a   Labopin, M ^b   Michallet, M ^b   Blaise, D ^b   Reiffers, J ^b   Meloni, G ^b   Rio, B ^b   Treleaven, J ^a   Horton, C ^a   Mehta, J ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b Eur Blood/Bone Marrow Transplant Gr ^*

^c NORTHWESTERN UNIVERSITY   (United States)

^d Parkside Oncology Clinic   (United Kingdom)

Author keywords

Acute myeloid leukaemia; Autologous bone marrow transplantation; Peripheral blood stem cells

Indexed keywords

AMSACRINE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HEMATOPOIESIS; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; KARYOTYPING; KRUSKAL WALLIS TEST; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL RATE; TIME;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; HEMATOPOIESIS; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MATCHED-PAIR ANALYSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROBABILITY; RECURRENCE; REGISTRIES; REMISSION INDUCTION; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 3242667168     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704511     Document Type: Article

References (31)

1. Burnett AK. Transplantation in first remission of acute myeloid leukemia. N Engl J Med 1998; 339: 1698-1700.
2. Cassileth PA, Harrington DP, Appelbaum FR et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998; 339: 1649-1656.
3. Burnett AK, Goldstone AH, Stevens RMF et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. Lancet 1998; 351: 700-708.
4. Child JA, Morgan GJ, Davies FE et al. High-dose chemotherapy with haematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875-1883.
5. Raje N, Powles R, Kulkarni S et al. A comparison of vincristine, doxorubicin infusional chemotherapy with methyl-prednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma. Br J Haematol 1997; 97: 153-160.
6. Mehta J, Powles R, Horton C et al. Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia. Bone Marrow Transplant 1996; 18: 319-324.
7. Mehta J, Powles R, Singhal S et al. Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant 1995; 15: 652-653.
8. Reiffers J, Labopin M, Sanz M et al. Autologous blood cell vs marrow transplantation for acute myeloid leukaemia in complete remission: an EBMT retrospective analysis. Bone Marrow Transplant 2000; 25: 1115-1119.
9. de Witte T, Keating S, Suciu S et al. A randomized comparison of the value of autologous BMT versus autologous PSCT for patients with AML in first CR in the AML 10 Trial of the EORTC LCG and GIMEMA. Blood 2001; 98: 859a.
10. Mehra J, Powles R, Treleaven J et al. The impact of karyotyping on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy. Leuk Lymphoma 1999; 34: 553-560.
11. Powles R, Milan S, Horton C et al. The Royal Marsden Hospital leukaemia-myeloma database: an 'Operations Research' resource for assessing clinical outcomes and planning new drug trials. Blood 2001; 98: 426a.
12. Wheatley K, Burnett AK, Goldstone AH et al. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. Br J Haematol 1999; 107: 69-79.
13. Mehta J, Powles R, Singhal S et al. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors. Bone Marrow Transplant 1995; 16: 499-506.
14. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952; 47: 583-621.
15. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
17. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia, The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattic Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217-223.
18. Harousseau JL, Cahn JY, Pignon B et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukaemia. Blood 1997; 90: 2978-2986.
19. Gorin NC, Aegerter P, Auvert B et al. Autologous bone marrow transplantation for acute myelocytic leukaemia in first remission: a European survey of the role of marrow purging. Blood 1990; 75: 1606-1614.
20. Gorin NC. Autologous stem cell transplantation for adult acute leukaemia. Curr Opin Oncol 2002; 14: 152-159.
21. Gorin NC, Labopin M. Treatment of acute myeloid leukaemia. N Engl J Med 1999; 340: 1437 (letter).
22. Powles R, Sirohi B, Treleaven J et al. The role of post-transplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukaemia. Blood 2002; 100: 1641-1647.
23. 2 melphalan. Blood 2001; 98: 684a.
24. Lazarus HM, Rowlings PA, Zhang MJ et al. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 1999; 17: 534-545.
25. Weaver CH, West W, Schwartzberg L et al. The rationale for performing autologous peripheralblood stem cell transplants in community cancer centers. Oncologist 1998; 3: 346-353.
26. de Witte T, Brand R, van Biezen A et al. Peripheral stem cells are the preferred source of stem cells for autologous stem cell transplantation (ASCT) of young patients with MDS or AML following MDS: an analysis of the Chronic Leukaemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Blood 2001; 98: 848a.
27. Thomas ED, Clift RA, Hersman J et al. Marrow transplantation for acute nonlymphoblastic leukaemia in first remission using fractionated or single-dose irradiation. Int J Rad Biol Phys 1981; 8: 817-821.
28. Deeg HJ, Sullivan KM, Buckner CD et al. Marrow transplantation for acute nonlymphoblastic leukaemia in first remission: toxicity and long-term follow-up of patients conditioned with single-dose or fractionated total body irradiation. Bone Marrow Transplant 1986; 1: 151-157.
29. Girinsky T, Benhamou E, Bourhis JH et al. Prospective randomised comparison of single-dose versus hyperfractionated total-body irradiation in patients with haematologic malignancies. J Clin Oncol 2000; 18: 981-986.
30. Powles R, Sirohi B, Treleaven J et al. Maximal response to infusional chemotherapy prior to autotransplantation influences outcome of patients with newly-diagnosed multiple myeloma. Blood 2000; 96: 292b.
31. Isnard F, Guiguet M, Laporte JP et al. Improved efficiency of remission induction facilitates autologous BMT harvesting and improves overall survival in adults with AML: 108 patients treated at a single institution. Bone Marrow Transplant 2001; 27: 1045-1052.